Terms: = Germ cell tumor AND HEY1, CHF-2, 23462, ENSG00000164683, HESR1, CHF2, HESR-1, MGC1274, HRT-1, OAF1, HERP2
30 results:
1. Identification of angiogenesis-related genes signature for predicting survival and its regulatory network in glioblastoma.
Wan Z; Zuo X; Wang S; Zhou L; Wen X; Yao Y; Song J; Gu J; Wang Z; Liu R; Luo C
Cancer Med; 2023 Aug; 12(16):17445-17467. PubMed ID: 37434432
[TBL] [Abstract] [Full Text] [Related]
2. Tracing the origins of glioblastoma by investigating the role of gliogenic and related neurogenic genes/signaling pathways in GBM development: a systematic review.
Shafi O; Siddiqui G
World J Surg Oncol; 2022 May; 20(1):146. PubMed ID: 35538578
[TBL] [Abstract] [Full Text] [Related]
3. POFUT1 acts as a tumor promoter in glioblastoma by enhancing the activation of Notch signaling.
Li Q; Wang J; Ma X; Wang M; Zhou L
J Bioenerg Biomembr; 2021 Oct; 53(5):621-632. PubMed ID: 34251584
[TBL] [Abstract] [Full Text] [Related]
4. A computational guided, functional validation of a novel therapeutic antibody proposes Notch signaling as a clinical relevant and druggable target in glioma.
Herrera-Rios D; Li G; Khan D; Tsiampali J; Nickel AC; Aretz P; Hewera M; Suwala AK; Jiang T; Steiger HJ; Kamp MA; Muhammad S; Hänggi D; Maciaczyk J; Zhang W; Kahlert UD
Sci Rep; 2020 Oct; 10(1):16218. PubMed ID: 33004830
[TBL] [Abstract] [Full Text] [Related]
5. N-acetylcysteine decreases malignant characteristics of glioblastoma cells by inhibiting Notch2 signaling.
Deng J; Liu AD; Hou GQ; Zhang X; Ren K; Chen XZ; Li SSC; Wu YS; Cao X
J Exp Clin Cancer Res; 2019 Jan; 38(1):2. PubMed ID: 30606241
[TBL] [Abstract] [Full Text] [Related]
6. An update of molecular pathology of bone tumors. Lessons learned from investigating samples by next generation sequencing.
Baumhoer D; Amary F; Flanagan AM
Genes Chromosomes Cancer; 2019 Feb; 58(2):88-99. PubMed ID: 30582658
[TBL] [Abstract] [Full Text] [Related]
7. Nuclear Factor I Represses the Notch Effector hey1 in Glioblastoma.
Brun M; Jain S; Monckton EA; Godbout R
Neoplasia; 2018 Oct; 20(10):1023-1037. PubMed ID: 30195713
[TBL] [Abstract] [Full Text] [Related]
8. hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growth.
Ménard M; Costechareyre C; Ichim G; Blachier J; Neves D; Jarrosson-Wuilleme L; Depping R; Koster J; Saintigny P; Mehlen P; Tauszig-Delamasure S
PLoS Biol; 2018 May; 16(5):e2002912. PubMed ID: 29750782
[TBL] [Abstract] [Full Text] [Related]
9. Copy number alterations determined by single nucleotide polymorphism array testing in the clinical laboratory are indicative of gene fusions in pediatric cancer patients.
Busse TM; Roth JJ; Wilmoth D; Wainwright L; Tooke L; Biegel JA
Genes Chromosomes Cancer; 2017 Oct; 56(10):730-749. PubMed ID: 28597942
[TBL] [Abstract] [Full Text] [Related]
10. Methylation regulates hey1 expression in glioblastoma.
Tsung AJ; Guda MR; Asuthkar S; Labak CM; Purvis IJ; Lu Y; Jain N; Bach SE; Prasad DVR; Velpula KK
Oncotarget; 2017 Jul; 8(27):44398-44409. PubMed ID: 28574840
[TBL] [Abstract] [Full Text] [Related]
11. Notch4 Signaling Induces a Mesenchymal-Epithelial-like Transition in Melanoma cells to Suppress Malignant Behaviors.
Bonyadi Rad E; Hammerlindl H; Wels C; Popper U; Ravindran Menon D; Breiteneder H; Kitzwoegerer M; Hafner C; Herlyn M; Bergler H; Schaider H
Cancer Res; 2016 Apr; 76(7):1690-7. PubMed ID: 26801977
[TBL] [Abstract] [Full Text] [Related]
12. A combined gene signature of hypoxia and notch pathway in human glioblastoma and its prognostic relevance.
Irshad K; Mohapatra SK; Srivastava C; Garg H; Mishra S; Dikshit B; Sarkar C; Gupta D; Chandra PS; Chattopadhyay P; Sinha S; Chosdol K
PLoS One; 2015; 10(3):e0118201. PubMed ID: 25734817
[TBL] [Abstract] [Full Text] [Related]
13. Notch signaling activation in pediatric low-grade astrocytoma.
Brandt WD; Schreck KC; Bar EE; Taylor I; Marchionni L; Raabe E; Eberhart CG; Rodriguez FJ
J Neuropathol Exp Neurol; 2015 Feb; 74(2):121-31. PubMed ID: 25575134
[TBL] [Abstract] [Full Text] [Related]
14. Hypoxia promotes uveal melanoma invasion through enhanced Notch and MAPK activation.
Asnaghi L; Lin MH; Lim KS; Lim KJ; Tripathy A; Wendeborn M; Merbs SL; Handa JT; Sodhi A; Bar EE; Eberhart CG
PLoS One; 2014; 9(8):e105372. PubMed ID: 25166211
[TBL] [Abstract] [Full Text] [Related]
15. Crosstalk between glioma-initiating cells and endothelial cells drives tumor progression.
Jeon HM; Kim SH; Jin X; Park JB; Kim SH; Joshi K; Nakano I; Kim H
Cancer Res; 2014 Aug; 74(16):4482-92. PubMed ID: 24962027
[TBL] [Abstract] [Full Text] [Related]
16. Notch1 stimulation induces a vascularization switch with pericyte-like cell differentiation of glioblastoma stem cells.
Guichet PO; Guelfi S; Teigell M; Hoppe L; Bakalara N; Bauchet L; Duffau H; Lamszus K; Rothhut B; Hugnot JP
Stem Cells; 2015 Jan; 33(1):21-34. PubMed ID: 24898819
[TBL] [Abstract] [Full Text] [Related]
17. USP11 regulates PML stability to control Notch-induced malignancy in brain tumours.
Wu HC; Lin YC; Liu CH; Chung HC; Wang YT; Lin YW; Ma HI; Tu PH; Lawler SE; Chen RH
Nat Commun; 2014; 5():3214. PubMed ID: 24487962
[TBL] [Abstract] [Full Text] [Related]
18. Id2 mediates oligodendrocyte precursor cell maturation arrest and is tumorigenic in a PDGF-rich microenvironment.
Havrda MC; Paolella BR; Ran C; Jering KS; Wray CM; Sullivan JM; Nailor A; Hitoshi Y; Israel MA
Cancer Res; 2014 Mar; 74(6):1822-32. PubMed ID: 24425046
[TBL] [Abstract] [Full Text] [Related]
19. Thiocoraline alters neuroendocrine phenotype and activates the Notch pathway in MTC-TT cell line.
Tesfazghi S; Eide J; Dammalapati A; Korlesky C; Wyche TP; Bugni TS; Chen H; Jaskula-Sztul R
Cancer Med; 2013 Oct; 2(5):734-43. PubMed ID: 24403239
[TBL] [Abstract] [Full Text] [Related]
20. Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.
Fang KM; Lin TC; Chan TC; Ma SZ; Tzou BC; Chang WR; Liu JJ; Chiou SH; Yang CS; Tzeng SF
Glia; 2013 Sep; 61(9):1402-17. PubMed ID: 23832679
[TBL] [Abstract] [Full Text] [Related]
[Next]
